Latest Patents News

Janus Electric has locked in a $2.75 million R&D finance facility, strengthening its cash position to push forward with its zero-emission transport innovations. This strategic funding avoids shareholder dilution while supporting ongoing technology development.

Critical Resources Limited has successfully demonstrated a solvent-free Dry Supersonic Deposition method to fabricate lithium iron phosphate cathodes, marking a significant step toward scalable, energy-efficient solid-state battery manufacturing.

Advanced Innergy Holdings Ltd (AIH) has acquired Imenco Aqua AS, enhancing its marine technology platform with patented aquaculture solutions and recurring revenue streams in key global markets.

ClearVue Technologies has locked in a $3 million structured funding facility tied to its R&D tax credits, aiming to accelerate certification milestones and commercial deployment without diluting shareholders.

Cobalt Blue Holdings has confirmed its cobalt sulphate meets stringent battery precursor specifications, advancing its Kwinana Cobalt Refinery toward a Final Investment Decision. The company also expands its graphite recovery program, positioning itself at the forefront of Australia’s battery materials ecosystem.

Control Bionics has secured a key regulatory milestone with its NeuroNode device now eligible for reimbursement under Germany’s statutory health insurance, paving the way for expanded European distribution.

Metal Powder Works has partnered with CenterLine to develop Kirksite alloy powders for cold spray automotive tooling, targeting a USD 100-300 million market. This collaboration aims to enhance tooling repair speed and cost-efficiency in the automotive sector.

FBR Limited reports a significant reduction in half-year losses alongside new robotic product launches, yet cash flow challenges raise questions about its financial sustainability.

ClearVue Technologies reported a 9% reduced half-year loss of $5.25 million, while pushing forward with significant advancements in its solar glass technology and expanding global licensing partnerships.

Recce Pharmaceuticals reported a doubling of its net loss for the half-year ended December 2025 amid significant progress in its anti-infective drug development and a substantial funding boost. The company is advancing Phase 3 trials and expanding its patent portfolio while managing financial pressures.

Codeifai Limited reported a 26% revenue decline to $598,497 for 2025 alongside a sharp increase in net loss to $6.22 million, driven by strategic investments and market challenges. The company’s pivot to self-service SaaS platforms, including a key acquisition post-year-end, signals a transformative but uncertain path forward.

Janus Electric Holdings reported a 46% increase in net loss to $4.93 million for the half-year ended December 2025, driven by rising costs despite a 33% revenue boost. The company faces funding uncertainties as it pursues key investments and operational scale-up.